Cooper Companies Inc  

(Public, NYSE:COO)   Watch this stock  
Find more results for Daniel R. Cooper
-0.69 (-0.51%)
Feb 12 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 133.25 - 134.98
52 week 119.28 - 190.00
Open 134.62
Vol / Avg. 513,935.00/514,209.00
Mkt cap 6.43B
P/E 32.30
Div/yield 0.03/0.04
EPS 4.14
Shares 48.39M
Beta 0.20
Inst. own 108%
Mar 15, 2016
Cooper Companies Inc Annual Shareholders Meeting (Estimated) Add to calendar
Mar 14, 2016
Cooper Companies Inc Annual Shareholders Meeting - 11:00AM EDT - Add to calendar
Mar 3, 2016
Q1 2016 Cooper Companies Inc Earnings Call - 5:00PM EST - Add to calendar
Mar 3, 2016
Q1 2016 Cooper Companies Inc Earnings Release - 4:15PM EST - Add to calendar
Jan 12, 2016
Cooper Companies Inc at JPMorgan Healthcare Conference
Dec 8, 2015
Cooper Companies Inc at Oppenheimer Healthcare Conference
Dec 3, 2015
Q4 2015 Cooper Companies Inc Earnings Call - Webcast
Dec 3, 2015
Q4 2015 Cooper Companies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '15) 2015
Net profit margin 8.13% 11.42%
Operating margin 9.28% 13.17%
EBITD margin - 23.82%
Return on average assets 3.34% 4.60%
Return on average equity 5.49% 7.77%
Employees 10,200 -
CDP Score - -


6140 Stoneridge Mall Rd Ste 590
PLEASANTON, CA 94588-3772
United States - Map
+1-925-4603600 (Phone)
+1-510-4603649 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


The Cooper Companies, Inc. (Cooper), is a global medical device company. The Company operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital, Office and Fertility Clinic. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism, presbyopia and ocular dryness, and provides innovative contact lens solutions. The CooperVision Company’s brands include Biofinity, Avaira and MyDay and CooperSurgical Company’s brands include Advincula Arch, SeeClear and Mobius.

Officers and directors

A. Thomas Bender Independent Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Weiss Chief Executive Officer, Director
Age: 69
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Allan E. Rubenstein M.D. Vice Chairman of the Board, Lead Director, Independent Director
Age: 71
Bio & Compensation  - Reuters
Gregory W. Matz Chief Financial Officer, Senior Vice President, Chief Risk Officer
Age: 56
Bio & Compensation  - Reuters
Paul L. Remmell President and Chief Executive Officer of CooperSurgical Inc.
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel G. McBride Esq. Chief Operating Officer, Executive Vice President; President of CooperVision, Inc.
Age: 51
Bio & Compensation  - Reuters
Carol R. Kaufman Executive Vice President, Chief Administrative Officer, Secretary, Chief Governance Officer
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Albert G. White III Executive Vice President, CHIEF STRATEGY OFFICER
Age: 46
Bio & Compensation  - Reuters
Randal L. Golden Esq. Vice President, General Counsel
Age: 54
Bio & Compensation  - Reuters
Tina F. Maloney Vice President, Controller
Age: 53
Bio & Compensation  - Reuters